Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen 600 mg ER for Dental Pain
NCT00707057Phase 3Completed
- Sponsor
- SCOLR Pharma
- Start
- Jun 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in odontalgia comparing Ibuprofen 600 mg ER with Placebo (2 arms). Primary endpoints: Sum of Pain Intensity Differences and Durability of Effect (Meaningful Improvement in PID) at 48 hours. Started Jun 2008; status: completed.
02
Drugs
ibuprofen
03
Conditions
odontalgia
Beyond the preview
Go deeper on NCT00707057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00707057.